4//SEC Filing
Cearnal Martin E 4
Accession 0001209191-21-067878
CIK 0001087294other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:05 PM ET
Size
36.1 KB
Accession
0001209191-21-067878
Insider Transaction Report
Form 4
Cearnal Martin E
Director
Transactions
- Purchase
Common Stock
2021-11-29$2.23/sh+175$390→ 176,184 total - Purchase
Common Stock
2021-11-30$4.61/sh+175$807→ 176,359 total - Purchase
Common Stock
2021-11-12$2.67/sh+105$280→ 174,924 total - Purchase
Common Stock
2021-11-17$2.58/sh+105$271→ 175,239 total - Purchase
Common Stock
2021-11-02$2.63/sh+105$276→ 174,084 total - Purchase
Common Stock
2021-11-04$2.73/sh+105$287→ 174,294 total - Purchase
Common Stock
2021-11-08$2.95/sh+105$310→ 174,504 total - Purchase
Common Stock
2021-11-01$2.67/sh+105$280→ 173,979 total - Purchase
Common Stock
2021-11-18$2.58/sh+105$271→ 175,344 total - Purchase
Common Stock
2021-11-03$2.71/sh+105$285→ 174,189 total - Purchase
Common Stock
2021-11-05$2.71/sh+105$285→ 174,399 total - Purchase
Common Stock
2021-11-09$3.21/sh+105$337→ 174,609 total - Purchase
Common Stock
2021-11-10$2.94/sh+105$309→ 174,714 total - Purchase
Common Stock
2021-11-15$2.71/sh+105$285→ 175,029 total - Purchase
Common Stock
2021-11-11$2.83/sh+105$297→ 174,819 total - Purchase
Common Stock
2021-11-16$2.66/sh+105$279→ 175,134 total - Purchase
Common Stock
2021-11-22$2.35/sh+105$247→ 175,554 total - Purchase
Common Stock
2021-11-24$2.31/sh+175$404→ 175,834 total - Purchase
Common Stock
2021-11-19$2.55/sh+105$268→ 175,449 total - Purchase
Common Stock
2021-11-23$2.29/sh+105$240→ 175,659 total - Purchase
Common Stock
2021-11-26$2.26/sh+175$395→ 176,009 total
Footnotes (1)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001408500
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:05 PM ET
- Size
- 36.1 KB